v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
SALES $ 155,650 $ 60,826
COST OF SALES (excluding depreciation expense) 31,384 15,495
GROSS PROFIT 124,266 45,331
OPERATING EXPENSES:    
Compensation and related benefits (including stock-based compensation of $3,902,480 and $361,380 for the three months ended March 31, 2021 and 2020, respectively) 4,575,113 689,370
Research and development 842 2,390
Professional fees 224,753 136,541
General and administrative expenses 169,156 105,195
Total Operating Expenses 4,969,864 933,496
LOSS FROM OPERATIONS (4,845,598) (888,165)
OTHER INCOME (EXPENSES):    
Derivative expense   (378,920)
Interest expense (18,375) (241,203)
Total Other Income (Expenses) (18,375) (620,123)
NET LOSS (4,863,973) (1,508,288)
Preferred stock dividend and deemed dividend (2,855,576)  
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (7,719,549) $ (1,508,288)
NET LOSS PER COMMON SHARE:    
Basic and diluted (in Dollars per share) $ (0.03) $ (0.01)
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:    
Basic and diluted (in Shares) 230,906,432 117,854,602

Source